tradmap

PG Financials Procter & Gamble

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 3.5% per year over the past 5 years.
  • Net income has grown faster than revenue (4.2% vs 3.5% per year).
  • Operating margin has expanded, at 24.3% in the latest year.
  • Free cash flow has declined 0.4% per year over the past 5 years.

Financial health

  • Total debt ($34.5B) exceeds cash ($9.6B); net debt is $24.9B.
  • Total debt has grown slower than revenue (-0.1% vs 3.5% per year).
  • Operating income covered interest expense 23× in the latest year.
  • Total debt is 1.5× EBITDA.

Shareholder returns

  • Dividends have been paid for 15 consecutive years, consuming 61.8% of earnings and 70.3% of free cash flow.
  • The dividend has grown 4.9% per year over the past 5 years.
Revenue & net income
$0 $42B $84B 2011 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
0% 26% 51% 2011 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Free cash flow (CFO − capex)
$0 $8B $17B 2011 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $19B $37B 2011 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$22B -$843M $20B $0 2011 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MFCFTotal debtCash
2025 $84.3B $16.0B 51.2% 24.3% $14.0B $34.5B $9.6B
2024 $84.0B $14.9B 51.4% 22.1% $16.5B $32.4B $9.5B
2023 $82.0B $14.7B 47.9% 22.1% $13.8B $34.6B $8.2B
2022 $80.2B $14.7B 47.4% 22.2% $13.6B $31.3B $7.2B
2021 $76.1B $14.3B 51.2% 23.6% $15.6B $31.9B $10.3B
2020 $71.0B $13.0B 50.3% 22.1% $14.3B $34.6B $16.2B
2019 $67.7B $3.9B 48.6% 8.1% $11.9B $30.0B $4.2B
2018 $66.8B $9.8B 48.5% 20.0% $11.2B $30.4B $2.6B
2017 $65.1B $15.3B 49.8% 21.2% $9.4B $31.4B $5.6B
2016 $10.5B $12.1B $30.4B
2015 $7.0B $10.9B $31.9B
2014 $29.4B $11.6B 0.0% 47.3% $10.1B $37.2B
2013 $29.2B $11.3B 0.0% 44.7% $10.9B $31.3B
2012 $28.4B $10.8B 0.0% 45.9% $9.3B $32.5B
2011 $11.8B $10.0B $33.4B

Valuation over time

How the market has priced PG against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 14.0 28.1 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/E
Price / sales (P/S)
0.0 2.5 5.0 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/S
Dividend yield (%)
0.0 1.5 3.0 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
Dividend yield %

Frequently asked questions

Is PG growing its revenue and profit?

Over the past 5 years, Procter & Gamble's revenue has grown 3.5% per year, and net income grown 4.2% per year. These are computed facts, not advice.

How much debt does PG have?

As of FY2025, Procter & Gamble reported $34.5B of total debt against $9.6B of cash; operating income covered interest expense 23×.

What is PG's profit margin?

In FY2025, gross margin was 51.2%, operating margin 24.3%, and net margin 19.0%.

What is PG's P/E ratio?

As of Jun '26, Procter & Gamble traded at a price-to-earnings ratio of about 21.7× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.